Eagle Pharmaceuticals Inc (EGRX) Insider Trading
- $6,655,741.73
- $139,852,839.96
- Nov. 1, 2023
- Proquest Investments Iv, L.P.
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Aug. 15, 2016 | Major Shareholder | 24,949 | $60.77 | Sell | $1,516,150.73 | |
| May 13, 2016 | Major Shareholder | 17,980 | $40.72 | Sell | $732,145.60 | |
| April 1, 2016 | CEO | 30,765 | $40.63 | Sell | $1,249,981.95 | |
| March 15, 2016 | Director | 1,000 | $56.73 | Buy | $56,730.00 | |
| Feb. 1, 2016 | CEO | 18,360 | $68.08 | Sell | $1,249,948.80 | |
| Dec. 22, 2015 | Director | 13,025 | $54.81 | Sell | $713,900.25 | |
| Dec. 1, 2015 | CEO | 14,050 | $88.93 | Sell | $1,249,466.50 | |
| Nov. 2, 2015 | CEO | 19,339 | $64.63 | Sell | $1,249,879.57 | |
| Oct. 1, 2015 | CEO | 17,878 | $69.92 | Sell | $1,250,029.76 | |
| Sept. 1, 2015 | CEO | 16,245 | $76.95 | Sell | $1,250,052.75 | |
| July 1, 2015 | CEO | 135,710 | $46.34 | Sell | $6,288,801.40 | |
| June 16, 2015 | Insider | 9,980 | $81.60 | Sell | $814,368.00 | |
| Feb. 18, 2014 | Director | 333,333 | $15.00 | Buy | $4,999,995.00 |
Insiders are both buying and selling Eagle Pharmaceuticals Inc stock.
The insider traders at Eagle Pharmaceuticals Inc are: Proquest Investments Iv, L.P., Scott Tarriff, Hudson Executive Capital Lp, David Pernock, Steven L Krill, Douglas L Braunstein, Pete A Meyers, Richard A Edlin, Sander A Flaum, Jay Moorin, Sander A. Flaum, Michael Graves, Proquest Management Llc, and Steven B Ratoff
The most active insider trader at Eagle Pharmaceuticals Inc is Proquest Investments Iv, L.P. with 20 trades.
Proquest Investments Iv, L.P. has sold the most Eagle Pharmaceuticals Inc stock with a total value of $107,816,295.02.
Jay Moorin has bought the most Eagle Pharmaceuticals Inc stock with a total value of $9,999,990.00.
The most recent insider trade for Eagle Pharmaceuticals Inc was on Nov. 1, 2023.
The single biggest insider buy for Eagle Pharmaceuticals Inc was from Jay Moorin with a total value of $4,999,995.00 on Feb. 18, 2014.
The single biggest insider sell for Eagle Pharmaceuticals Inc was from Proquest Investments Iv, L.P. with a total value of $17,454,585.40 on Nov. 4, 2016.